Business, energy, technology, markets and global industry news from Business News Today

critical care

PharmaDeviceNews critical care
Representative image of an intensive care unit ventilator setup, highlighting how diaphragm stimulation devices such as Lungpacer Medical’s AeroPace System could help hospitals support faster ventilator weaning in critically ill patients.
Medical Devices & Diagnostics

Can Lungpacer Medical’s AeroPace System change the economics of ventilator recovery?

AeroPace moves into East Coast ICU care as hospitals test whether diaphragm stimulation can shorten ventilator recovery. Read the analysis.

Read More
Representative image of a transport-ready ECMO system in a critical care transfer setting, reflecting Medtronic plc’s CE mark approval for the VitalFlow Transport Frame Air and Ground in Europe.
Medical Devices & Diagnostics

Medtronic just cleared a key ECMO transport hurdle, but hospitals still face the harder test

ECMO transport is a clinical weak point. Medtronic’s VitalFlow CE mark tests whether device mobility can strengthen critical care networks.

Read More
Representative image of ICU-based sepsis care and immune pathway monitoring, relevant to the EMBRACE clinical trial evaluating emapalumab in interferon-gamma-driven sepsis (IDS).
Pharma & Biotech

Sepsis breakthrough? What the EMBRACE trial reveals about Sobi’s emapalumab strategy

Swedish Orphan Biovitrum AB (Sobi) has reported positive topline data from the Phase 2a EMBRACE trial of Gamifant (emapalumab) in interferon-gamma-driven sepsis (IDS), demonstrating organ function improvement and a potential survival benefit. Based on the signal, the drug will advance in development in collaboration with the Hellenic Institute for the Study of Sepsis (HISS). The

Read More